Stability and repeat regeneration potential of the engineered liver tissues under the kidney capsule in mice

Cell Transplantation

Volumn 14, Issue 9, 2005, Pages 621-627

  Ohashi, Kazuo ^a,b   Kay, Mark A ^b   Yokoyama, Takashi ^a   Kuge, Hiroyuki ^a   Kanehiro, Hiromichi ^a   Hisanaga, Michiyoshi ^a   Ko, Saiho ^a   Nakajima, Yoshiyuki ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hepatocyte transplantation; Liver failure; Liver regeneration; Regenerative medicine; Tissue engineering

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL ISOLATION; CELL STIMULATION; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HEPATOCYTE TRANSPLANTATION; KIDNEY CAPSULE; LIVER FAILURE; LIVER REGENERATION; LIVER RESECTION; MOUSE; NONHUMAN; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; PURIFICATION; TECHNIQUE; TISSUE ENGINEERING; TREATMENT OUTCOME;

ALPHA 1-ANTITRYPSIN; ANIMALS; GRAFT SURVIVAL; HEPATECTOMY; HEPATOCYTES; HUMANS; LIVER REGENERATION; MICE; MICE, TRANSGENIC; SUBRENAL CAPSULE ASSAY; TISSUE ENGINEERING;

ANIMALIA;

EID: 29544448109     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000005783982620     Document Type: Conference Paper

References (24)

1. Ajioka, I.; Akaike, T.; Watanabe, Y. Expression of vascular endothelial growth factor promotes colonization, vascularization, and growth of transplanted hepatic tissues in the mouse. Hepatology 29:396-402; 1999.
2. Berry, M. N.; Friend, D. S. High-yield preparation of isolated rat liver parenchymal cells: A biochemical and fine structural study. J. Cell Biol. 43:506-520; 1969.
3. Bumgardner, G. L.; Li, J.; Heininger, M.; Ferguson, R. M.; Orosz, C. G. In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model. Transplant 65:47-52; 1998.
4. Fausto, N. Liver regeneration. In: Arias, I. M.; Boyer, J. L.; Chisari, F. V.; Fausto, N.; Schachter, D.; Shafritz, D. A., eds. The liver. Biology and pathobiology, 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001: 591-610.
5. Fox, I. J.; Chowdhury, J. R.; Kaufman, S. S.; Goertzen, T. C.; Chowdhury, N. R.; Warkentin, P. I.; Dorko, K.; Sauter, B. V.; Strom, S. C. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N. Engl. J. Med. 338:1422-1426; 1998.
6. Kaufmann, P. M.; Sano, K.; Uyama, S.; Takeda, T.; Vacanti, J. P. Heterotopic hepatocyte transplantation: Assessing the impact of hepatotrophic stimulation. Transplant. Proc. 26:2240-2241; 1994.
7. Kay, M. A.; Glorioso, J. C.; Naldini, L. Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics. Nat. Med. 7:33-40; 2001.
8. Michalopoulos, G. K.; DeFrances, M. C. Liver regeneration. Science 276:60-66; 1997.
9. Muraca, M.; Gerunda, G.; Neri, D.; Vilei, M. T.; Granato, A.; Feltracco, P.; Meroni, M.; Giron, G.; Burlina, A. B. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 59:317-318; 2002.
10. Nakamura, J.; Okamoto, T.; Schumacher, I. K.; Tabei, I.; Chowdhury, N. R.; Chowdhury, J. R.; Fox, I. J. Treatment of surgically induced acute liver failure by transplantation of conditionally immortalized hepatocytes. Transplantation 63:1541-1547; 1997.
11. Nguyen, T. H.; Oberholzer, J.; Birraux, J.; Majno, P.; Morel, P.; Trono, D. Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. Mol. Ther. 6:199-209; 2002.
12. Ochoa, E.; Vacanti, J. P. An overview of the pathology and approaches to tissue engineering. Ann. NY. Acad. Sci. 979:10-26; 2002.
13. Ohashi, K.; Park, F.; Kay, M. A. Hepatocyte transplantation: Clinical and experimental application. J. Mol. Med. 79:617-630; 2001.
14. Ohashi, K.; Park, F.; Kay, M. A. Role of hepatocyte direct hyperplasia in lentivirus-mediated liver transduction in vivo. Hum. Gene. Ther. 13:653-663; 2002.
15. Ohashi, K.; Park, F.; Schwall, R.; Kay, M. Efficient gene transduction to cultured hepatocytes by HIV-1 derived lentiviral vector. Transplant. Proc. 34:1431-1433; 2002.
16. Ohashi, K.; Marion, P. L.; Nakai, H.; Meuse, L.; Cullen, J. M.; Bordier, B. B.; Schwall, R.; Greenberg, H. B.; Glenn, J. S.; Kay, M. A. Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses. Nat. Med. 6: 327-331; 2000.
17. Ohashi, K.; Nakajima, Y.; Kay, M. A. Engineering liver tissues at the kidney capsule in mice. Mol. Ther. 7:S391; 2003.
18. Ohashi, K.; Waugh, J. M.; Dake, M. D.; Yokoyama, T.; Kuge, H.; Nakajima, Y.; Yamanouchi, M.; Naka, H.; Yoshioka, A.; Kay, M. A. Liver tissue engineering at extra-heptic sites in mice as a potential new therapy for genetic liver diseases. Hepatology 41:132-140; 2005.
19. Ohashi, K.; Tsutsumi, M.; Tsujiuchi, T.; Kobitsu, K.; Okajima, E.; Nakajima, Y.; Nakano, H.; Takahashi, M.; Mori, Y.; Konishi, Y. Enhancement of N-nitrosodiethylamine-initiated hepatocarcinogenesis caused by a colchicines-induced cell cycle disturbance in partially hepatectomized rats. Cancer Res. 56:3474-3479; 1996.
20. Overturf, K.; Al-Dhalimy, M.; Finegold, M.; Grompe, M. The repopulation potential of hepatocyte populations differing in size and prior mitotic expansion. Am. J. Pathol. 155:2135-2143; 1999.
21. Park, F.; Ohashi, K.; Kay, M. A. The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo. Mol. Ther. 8:314-323; 2003.
22. Rhim, J. A.; Sandgren, E. P.; Degen, J. L.; Palmiter, R. D.; Brinster, R. L. Replacement of diseased mouse liver by hepatic cell transplantation. Science 263:1149-1152; 1994.
23. Strom, S.; Fisher, R. Hepatocyte transplantation: New possibilities for therapy. Gastroenterology 124:568-571; 2003.
24. Vrancken Peeters, M. J.; Patijn, G. A.; Lieber, A.; Perkins, J.; Kay, M. A. Expansion of donor hepatocytes after recombinant adenovirus-induced liver regeneration in mice. Hepatology 25:884-888; 1997.